Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2017-04-13 2017-04-13
Drug Identification Number 02407302 02407302
Brand name GEMCITABINE FOR INJECTION, USP GEMCITABINE FOR INJECTION, USP
Common or Proper name Gemcitabine Gemcitabine
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients GEMCITABINE GEMCITABINE
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code L01BC L01BC
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-04-12 2017-04-12
Remaining supply date 2017-04-10 2017-04-10
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments